Skip to main content

Table 1 Malignancy reports by TNF blocker indication for patients ≤ 30 years old in the PMD a

From: Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports

Age group, years

JIA

RA

AS

PsA

Psoriasis

Other

Not reported

Total

0 to <6

1

0

0

0

0

0

1

2

6 to <12

4

0

0

0

0

0

0

4

12 to <18

7

0

0

0

0

2

4

13

18 to 30

8

29

14

5

17

2

4

79

Unknown

0

0

2

0

3

0

0

5

Total

20

29

16

5

20

4

9

103

  1. aData represent number of cases reported.
  2. AS, ankylosing spondylitis; JIA, juvenile idiopathic arthritis; PMD, postmarketing database; PsA, psoriatic arthritis; RA, rheumatoid arthritis; TNF, tumor necrosis factor.